Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayvon Modjarrad

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
The Lancet. Infectious Diseases|January 29, 2011
An addition to the effect of treating co-infections on HIV-1 viral loadKayvon Modjarrad, Sten H Vermund
Nature|February 22, 2013
AIDS epidemic: Iran needs global support to fight HIVKayvon Modjarrad, Minoo Mohraz, Navid Madani
Frontiers in Immunology|March 5, 2021
Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine DevelopmentVincent Dussupt, Kayvon Modjarrad, Shelly J Krebs
AIDS (London, England)|June 24, 2003
Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapyTraci E Yamashita, Kayvon Modjarrad, Alvaro Muñoz
The Journal of Infectious Diseases|August 10, 2016
Reply to LipsitchAndy Kilianski, Jennifer B Nuzzo, Kayvon Modjarrad
The Journal of Infectious Diseases|September 30, 2015
Gain-of-Function Research and the Relevance to Clinical PracticeAndy Kilianski, Jennifer B Nuzzo, Kayvon Modjarrad
AIDS (London, England)|October 4, 2008
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progressionKayvon Modjarrad, Eric Chamot, Sten H Vermund
Cell|July 11, 2020
Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in WeeksM Gordon Joyce, Adam K Wheatley, Kayvon Modjarrad
Current Opinion in Immunology|June 13, 2015
Novel antigens for RSV vaccinesBarney S Graham, Kayvon Modjarrad, Jason S McLellan
The Journal of Trauma|May 13, 2008
Association between upper extremity injuries and side airbag availabilityGerald McGwin, Kayvon Modjarrad, Stefan Duma, et al.
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
The Lancet. Infectious Diseases|January 29, 2011
An addition to the effect of treating co-infections on HIV-1 viral loadKayvon Modjarrad, Sten H Vermund
Nature|February 22, 2013
AIDS epidemic: Iran needs global support to fight HIVKayvon Modjarrad, Minoo Mohraz, Navid Madani
Frontiers in Immunology|March 5, 2021
Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine DevelopmentVincent Dussupt, Kayvon Modjarrad, Shelly J Krebs
AIDS (London, England)|June 24, 2003
Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapyTraci E Yamashita, Kayvon Modjarrad, Alvaro Muñoz
The Journal of Infectious Diseases|August 10, 2016
Reply to LipsitchAndy Kilianski, Jennifer B Nuzzo, Kayvon Modjarrad
The Journal of Infectious Diseases|September 30, 2015
Gain-of-Function Research and the Relevance to Clinical PracticeAndy Kilianski, Jennifer B Nuzzo, Kayvon Modjarrad
AIDS (London, England)|October 4, 2008
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progressionKayvon Modjarrad, Eric Chamot, Sten H Vermund
Cell|July 11, 2020
Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in WeeksM Gordon Joyce, Adam K Wheatley, Kayvon Modjarrad
Current Opinion in Immunology|June 13, 2015
Novel antigens for RSV vaccinesBarney S Graham, Kayvon Modjarrad, Jason S McLellan
The Journal of Trauma|May 13, 2008
Association between upper extremity injuries and side airbag availabilityGerald McGwin, Kayvon Modjarrad, Stefan Duma, et al.
Pageof 14